Clinical Approach to Shortness of Breath
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of shortness of breath
Shortness of breath, medically termed dyspnea, is one of the most common presenting complaints in primary care and emergency medicine. It accounts for approximately 3 to 4 million emergency department visits annually in the United States and represents about 8% of all ambulatory care visits. Chronic dyspnea affects an estimated 25% of adults in the general population and up to 50% of patients in tertiary care settings. The symptom carries significant prognostic weight—dyspnea is an independent predictor of mortality in patients with cardiac and pulmonary disease, making accurate diagnosis essential.
Definition
Dyspnea is the subjective experience of breathing discomfort that consists of qualitatively distinct sensations varying in intensity. It is a complex symptom arising from the interaction of multiple physiological, psychological, social, and environmental factors. Importantly, dyspnea is what the patient reports—it does not always correlate with objective measures such as oxygen saturation or respiratory rate.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Minutes to hours | Pulmonary embolism, pneumothorax, acute coronary syndrome, anaphylaxis, acute asthma exacerbation, pneumonia | Requires urgent evaluation; high likelihood of life-threatening etiology |
| Subacute | Days to weeks | Pneumonia, pleural effusion, heart failure exacerbation, anemia, early interstitial lung disease | Progressive pathology requiring timely workup; may represent decompensation of chronic disease |
| Chronic | Greater than 4 weeks | Chronic obstructive pulmonary disease, heart failure, asthma, interstitial lung disease, obesity, deconditioning | Most common presentation in primary care; often multifactorial; significant impact on quality of life |
Classification by Character
Exertional Dyspnea
Breathlessness occurring with physical activity. The degree of limitation is clinically important—dyspnea with moderate exertion (climbing stairs) suggests different pathology than dyspnea with minimal activity (dressing). Exertional dyspnea is characteristic of cardiac disease, chronic obstructive pulmonary disease, interstitial lung disease, anemia, and deconditioning.
Dyspnea at Rest
Breathlessness occurring without exertion. This is more concerning and often indicates advanced cardiopulmonary disease, severe anemia, metabolic acidosis, or significant anxiety or panic disorder. Acute onset of dyspnea at rest demands immediate evaluation for life-threatening causes.
Classification by Position and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Orthopnea | Dyspnea when lying flat, relieved by sitting upright | Heart failure, severe chronic obstructive pulmonary disease, diaphragmatic weakness, ascites |
| Paroxysmal Nocturnal Dyspnea | Sudden awakening at night with severe breathlessness, 1 to 2 hours after falling asleep | Heart failure (highly specific), nocturnal asthma |
| Platypnea | Dyspnea when upright, relieved by lying flat | Hepatopulmonary syndrome, intracardiac shunts, post-pneumonectomy |
| Trepopnea | Dyspnea when lying on one side but not the other | Unilateral lung disease, pleural effusion, cardiomegaly |
| Bendopnea | Dyspnea when bending forward (such as tying shoes) | Advanced heart failure with elevated filling pressures |
| Episodic or Intermittent | Recurrent attacks with symptom-free intervals | Asthma, panic disorder, arrhythmias, vocal cord dysfunction |
Qualitative Descriptors and Their Significance
How patients describe their breathlessness can provide diagnostic clues. Different pathophysiological mechanisms produce distinct sensory experiences:
| Patient Description | Likely Mechanism | Associated Conditions |
|---|---|---|
| “Chest tightness” or “constriction” | Bronchoconstriction, airway narrowing | Asthma, chronic obstructive pulmonary disease exacerbation |
| “Air hunger” or “need for more air” | Increased respiratory drive, hypercapnia, hypoxemia | Heart failure, pulmonary embolism, interstitial lung disease |
| “Work or effort to breathe” | Increased mechanical load, respiratory muscle fatigue | Chronic obstructive pulmonary disease, obesity, neuromuscular disease |
| “Cannot get a satisfying breath” | Often functional or anxiety-related | Hyperventilation syndrome, panic disorder, somatization |
| “Suffocating” or “smothering” | Severe hypoxemia or severe anxiety | Acute respiratory failure, severe panic attacks |
Key Concept: The “Big Four” of Chronic Dyspnea
In primary care, four conditions account for approximately 85% of chronic dyspnea cases:
- Asthma — approximately 25 to 30%
- Chronic obstructive pulmonary disease — approximately 25 to 30%
- Heart failure — approximately 15 to 20%
- Deconditioning and obesity — approximately 10 to 15%
However, up to two-thirds of patients have more than one contributing cause. A systematic approach is essential to identify all contributing factors.
Functional Assessment: Quantifying Dyspnea
Standardized scales help quantify the severity of dyspnea and track response to treatment:
| Modified Medical Research Council (mMRC) Grade | Description |
|---|---|
| Grade 0 | Dyspnea only with strenuous exercise |
| Grade 1 | Dyspnea when hurrying on level ground or walking up a slight hill |
| Grade 2 | Walks slower than people of the same age due to breathlessness, or has to stop for breath when walking at own pace on level ground |
| Grade 3 | Stops for breath after walking about 100 meters or after a few minutes on level ground |
| Grade 4 | Too breathless to leave the house or breathless when dressing or undressing |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of dyspnea
Dyspnea arises from a complex interplay between the respiratory system, cardiovascular system, and central nervous system. Unlike pain, which has dedicated nociceptors, the sensation of breathlessness emerges from the brain’s integration of multiple afferent signals and its comparison of these signals to the expected sensory feedback from a given respiratory motor output. When there is a mismatch between the motor command and the sensory feedback—termed “efferent-afferent mismatch”—the conscious sensation of dyspnea results.
Neural Control of Breathing and Dyspnea Perception
| Component | Structure | Function |
|---|---|---|
| Chemoreceptors | Central (medulla) and peripheral (carotid and aortic bodies) | Detect changes in carbon dioxide, oxygen, and pH; increase respiratory drive when abnormal |
| Mechanoreceptors | Lungs, airways, chest wall, respiratory muscles | Sense lung inflation, airway irritation, chest wall movement; provide feedback about breathing mechanics |
| Afferent Pathways | Vagus nerve, phrenic nerve afferents, intercostal nerves | Transmit sensory information from respiratory system to brainstem and cortex |
| Respiratory Centers | Medulla (ventral and dorsal respiratory groups), pons | Generate and regulate the rhythmic pattern of breathing |
| Cortical Processing | Insular cortex, anterior cingulate cortex, amygdala | Conscious perception of dyspnea; emotional and affective components of breathlessness |
| Efferent Pathways | Phrenic nerve, intercostal nerves, accessory muscle innervation | Motor commands to respiratory muscles; corollary discharge to sensory cortex |
Receptor Types and Clinical Relevance
Peripheral Chemoreceptors
Location: Carotid bodies (primary) and aortic bodies
Stimuli: Hypoxemia (partial pressure of oxygen less than 60 mmHg), hypercapnia, acidemia
Clinical relevance: Responsible for the sensation of “air hunger”; stimulated in pulmonary embolism, heart failure, anemia, and high altitude
Central Chemoreceptors
Location: Ventral surface of medulla
Stimuli: Elevated carbon dioxide (via cerebrospinal fluid pH changes)
Clinical relevance: Primary driver of respiratory sensation; responsible for dyspnea in hypercapnic respiratory failure; blunted in chronic hypercapnia (chronic obstructive pulmonary disease)
Pulmonary Receptors
Location: Airways (irritant receptors), lung parenchyma (stretch receptors, C-fibers)
Stimuli: Bronchoconstriction, inflammation, pulmonary congestion, interstitial edema
Clinical relevance: Contribute to chest tightness in asthma; activated in heart failure and interstitial lung disease; mediate cough reflex
The Three Primary Mechanisms of Dyspnea
Understanding the three fundamental mechanisms helps organize the differential diagnosis:
- Increased Respiratory Drive: Hypoxemia, hypercapnia, metabolic acidosis, and pulmonary vascular stimulation all increase the drive to breathe, creating the sensation of “air hunger” or “need for more air.”
- Increased Mechanical Load: Airway obstruction, reduced lung compliance, or chest wall abnormalities increase the work required to breathe, creating the sensation of “effort” or “work to breathe.”
- Respiratory Muscle Weakness: Neuromuscular diseases, cachexia, hyperinflation (which places the diaphragm at mechanical disadvantage), or fatigue impair the ability to generate adequate respiratory force.
How Common Conditions Cause Dyspnea
| Condition | Primary Mechanism(s) | Treatment Implication |
|---|---|---|
| Asthma | Bronchoconstriction increases airway resistance (mechanical load); airway inflammation stimulates irritant receptors; dynamic hyperinflation with severe attacks | Bronchodilators reduce resistance; anti-inflammatories decrease receptor stimulation |
| Chronic obstructive pulmonary disease | Expiratory airflow limitation with air trapping; hyperinflation flattens diaphragm (muscle disadvantage); hypercapnia in advanced disease | Bronchodilators improve airflow; pulmonary rehabilitation improves muscle efficiency; long-term oxygen for hypoxemia |
| Heart failure | Pulmonary congestion stimulates juxtacapillary (J) receptors; interstitial edema reduces compliance; hypoxemia from ventilation-perfusion mismatch | Diuretics reduce congestion; vasodilators improve forward flow; optimize cardiac output |
| Pulmonary embolism | Dead space ventilation; hypoxemia from ventilation-perfusion mismatch; reflex stimulation of pulmonary receptors; right heart strain | Anticoagulation restores perfusion; thrombolysis in massive pulmonary embolism; supportive oxygen |
| Interstitial lung disease | Reduced lung compliance (increased work); stimulation of parenchymal receptors; hypoxemia from diffusion impairment and ventilation-perfusion mismatch | Immunosuppression if inflammatory; antifibrotics if fibrotic; supplemental oxygen; pulmonary rehabilitation |
| Anemia | Reduced oxygen-carrying capacity leads to tissue hypoxia; compensatory increase in cardiac output and respiratory drive | Treat underlying cause; transfusion if severe; iron, vitamin B12, or folate replacement as indicated |
| Obesity | Increased mechanical load on chest wall; reduced functional residual capacity; ventilation-perfusion mismatch in dependent zones; increased metabolic demand | Weight loss; treatment of comorbid sleep apnea; pulmonary rehabilitation |
| Deconditioning | Reduced cardiovascular reserve; skeletal muscle inefficiency; earlier onset of anaerobic metabolism with lactic acidosis | Graded exercise training; cardiac and pulmonary rehabilitation |
| Anxiety and panic disorder | Central nervous system amplification of normal respiratory sensations; hyperventilation causing hypocapnia and symptoms; heightened interoceptive awareness | Cognitive behavioral therapy; breathing retraining; treatment of underlying anxiety disorder |
The Efferent-Afferent Mismatch Model
The currently accepted model for dyspnea perception centers on the concept of efferent-afferent mismatch:
Understanding Efferent-Afferent Mismatch
When the brain sends a motor command to the respiratory muscles (efferent signal), it simultaneously generates an expected sensory feedback pattern. If the actual sensory feedback from the respiratory system (afferent signals) does not match this expectation—because of increased airway resistance, reduced compliance, muscle weakness, or abnormal gas exchange—the resulting mismatch is perceived as dyspnea.
This model explains why patients with the same degree of lung function impairment may report vastly different levels of dyspnea, and why psychological factors significantly influence breathlessness perception.
Often Overlooked Mechanism: The Role of Cardiac Output
Dyspnea in heart failure is often attributed solely to pulmonary congestion, but reduced cardiac output plays an equally important role. When the heart cannot increase output during exertion, skeletal muscles become hypoxic earlier, producing lactic acid that stimulates chemoreceptors. This “muscle hypothesis” explains why dyspnea can be severe even when chest radiograph and lung function appear relatively preserved. It also explains why exercise training improves dyspnea in heart failure—by improving peripheral muscle oxygen utilization.
Consequences of Chronic Dyspnea
Persistent dyspnea initiates a vicious cycle that worsens functional capacity:
| Consequence | Mechanism | Clinical Impact |
|---|---|---|
| Activity avoidance | Patients limit activity to avoid breathlessness | Progressive deconditioning worsens exercise tolerance |
| Anxiety and depression | Dyspnea activates fear and anxiety circuits; chronic disability leads to depression | Psychological comorbidity amplifies dyspnea perception; reduces treatment adherence |
| Sleep disturbance | Orthopnea, paroxysmal nocturnal dyspnea, and associated cough disrupt sleep | Fatigue further limits activity and worsens quality of life |
| Social isolation | Inability to participate in normal activities; embarrassment about breathlessness | Reduced quality of life; worsening depression |
3. History Taking
A comprehensive approach to eliciting the dyspnea history
Red Flags — Require Urgent Evaluation
- Sudden onset at rest — Pulmonary embolism, pneumothorax, acute coronary syndrome
- Chest pain — Acute coronary syndrome, pulmonary embolism, pneumothorax, aortic dissection
- Hemoptysis — Pulmonary embolism, malignancy, tuberculosis
- Stridor or severe wheeze — Upper airway obstruction, anaphylaxis, severe asthma
- Altered mental status — Hypoxemia, hypercapnia, cardiogenic shock
- Syncope or near-syncope — Massive pulmonary embolism, arrhythmia, cardiac tamponade
- Unilateral leg swelling — Deep vein thrombosis with possible pulmonary embolism
- Recent surgery or immobilization — Pulmonary embolism risk
- Inability to speak in full sentences — Severe respiratory distress
- Tripod positioning or accessory muscle use — Impending respiratory failure
Systematic History: The “BREATHE” Approach
Use the mnemonic “BREATHE” to ensure comprehensive history taking for dyspnea:
- B — Beginning and pattern: When did it start? Sudden or gradual? Constant or intermittent? Getting better, worse, or stable?
- R — Related symptoms: Chest pain? Cough? Wheeze? Fever? Leg swelling? Palpitations? Weight changes?
- E — Exertion and position: Does it occur at rest or with exertion? How far can you walk? Can you lie flat? Wake at night?
- A — Aggravating and alleviating factors: What makes it worse? What makes it better? Response to inhalers or rest?
- T — Triggers and timing: Any identifiable triggers? Time of day? Seasonal? Related to meals or specific environments?
- H — History (medical, medications, social): Past cardiac or lung disease? Current medications? Smoking? Occupational exposures?
- E — Effect on life: Impact on daily activities? Sleep? Work? Quantify with mMRC scale.
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Heart failure | Orthopnea, paroxysmal nocturnal dyspnea, leg swelling, weight gain | “How many pillows do you sleep with? Do you ever wake up gasping for air at night? Have your ankles been swelling?” |
| Asthma | Episodic wheeze, triggers, nocturnal symptoms, atopy history | “Do you wheeze? Does cold air, exercise, or allergens trigger your breathing problems? Is it worse at night?” |
| Chronic obstructive pulmonary disease | Progressive exertional dyspnea, productive cough, smoking history | “How many pack-years have you smoked? Do you cough up phlegm most days? Has your exercise tolerance declined over months to years?” |
| Pulmonary embolism | Sudden onset, pleuritic chest pain, risk factors | “Did this come on suddenly? Do you have pain when you breathe deeply? Any recent surgery, travel, or leg swelling?” |
| Pneumonia | Fever, productive cough, pleuritic pain | “Do you have a fever? Are you coughing up colored sputum? Does it hurt to take a deep breath?” |
| Interstitial lung disease | Progressive dyspnea, dry cough, occupational or medication exposure | “Has your breathing slowly worsened over months? Do you have a dry cough? What work have you done? Any exposure to birds, mold, or dusts?” |
| Anemia | Fatigue, pallor, exertional symptoms, bleeding history | “Do you feel unusually tired? Have you noticed any bleeding or dark stools? Heavy menstrual periods?” |
| Anxiety or panic disorder | Episodic, associated fear, perioral tingling, palpitations | “Do you feel anxious or scared during episodes? Any tingling around your mouth or fingers? Do you feel your heart racing?” |
| Obesity and deconditioning | Gradual onset, proportional to activity, no other symptoms | “Has your weight changed recently? How active were you before this started? Does the breathlessness match what you’d expect for the activity?” |
| Pleural effusion | Positional dyspnea, dull chest discomfort, history of malignancy or heart failure | “Is your breathing worse when you lie on one particular side? Do you have any history of cancer or heart problems?” |
Quantifying Functional Limitation
Practical Questions to Assess Severity
Ask specific functional questions to quantify dyspnea and track changes over time:
- “How many flights of stairs can you climb before stopping?”
- “How far can you walk on flat ground before you need to rest?”
- “Can you keep up with people your own age when walking?”
- “Are you breathless when dressing or bathing?”
- “Do you need to stop to catch your breath when talking?”
Compare current function to baseline: “Six months ago, what could you do that you can’t do now?”
Medication and Social History
Medications That Can Cause Dyspnea
- Beta-blockers — Bronchospasm in susceptible patients; reduced exercise tolerance
- Amiodarone — Pulmonary toxicity (interstitial pneumonitis, fibrosis)
- Methotrexate — Hypersensitivity pneumonitis, interstitial lung disease
- Nitrofurantoin — Acute and chronic pulmonary reactions
- Bleomycin — Pulmonary fibrosis (dose-related)
- Nonsteroidal anti-inflammatory drugs — Bronchospasm in aspirin-sensitive asthma
- Angiotensin-converting enzyme inhibitors — Cough leading to perceived dyspnea; rare angioedema
- Illicit drugs — Cocaine (pulmonary edema, hemorrhage), opioids (respiratory depression), inhaled substances
Social and Occupational History
- Smoking: Quantify in pack-years; include marijuana, vaping, and secondhand exposure
- Occupation: Asbestos (shipyards, construction), silica (mining, sandblasting), coal dust, organic dusts (farmers, bird fanciers), isocyanates (painters, foam workers)
- Home environment: Mold, birds, humidifiers, feather bedding (hypersensitivity pneumonitis triggers)
- Travel: Endemic fungal infections (histoplasmosis, coccidioidomycosis); tuberculosis exposure
- Immobilization: Recent surgery, long flights, hospitalization (venous thromboembolism risk)
- Family history: Alpha-1 antitrypsin deficiency, familial pulmonary fibrosis, cardiomyopathy
Associated Symptoms and Their Significance
| Associated Symptom | Consider These Diagnoses | Follow-up Questions |
|---|---|---|
| Chest pain — pleuritic | Pulmonary embolism, pneumonia, pleuritis, pneumothorax | “Is the pain sharp and worse with breathing? Point to where it hurts.” |
| Chest pain — substernal pressure | Acute coronary syndrome, esophageal disease | “Does it feel like pressure or squeezing? Does it go to your arm or jaw?” |
| Cough — productive | Chronic obstructive pulmonary disease, pneumonia, bronchiectasis | “What color is the phlegm? How much? Any blood?” |
| Cough — dry | Interstitial lung disease, heart failure, angiotensin-converting enzyme inhibitor use, asthma | “Is it a dry, hacking cough? When did it start relative to any new medications?” |
| Wheeze | Asthma, chronic obstructive pulmonary disease, heart failure (“cardiac asthma”) | “Can you hear yourself wheeze? Is it when breathing in, out, or both?” |
| Lower extremity edema | Heart failure, cor pulmonale, venous insufficiency | “When did the swelling start? Is it both legs? Does it go down overnight?” |
| Palpitations | Arrhythmia (especially atrial fibrillation), anemia, anxiety | “Do you feel your heart racing or skipping? Is it regular or irregular?” |
| Fatigue | Anemia, heart failure, deconditioning, depression, hypothyroidism | “Are you more tired than usual? Do you feel weak or just short of breath?” |
| Weight loss | Malignancy, chronic obstructive pulmonary disease (cachexia), tuberculosis | “How much weight have you lost and over what period? Was it intentional?” |
| Fever | Pneumonia, tuberculosis, hypersensitivity pneumonitis | “Have you had fevers or chills? Night sweats?” |
4. Physical Examination
A systematic head-to-toe approach for dyspnea
Systematic Framework: Use the “General → Vital Signs → Head-to-Toe” approach for complete examination of patients presenting with dyspnea. Remember that the examination begins the moment you see the patient—observe their breathing, posture, and level of distress before any hands-on assessment.
General Inspection
- Level of distress: Comfortable at rest versus visibly dyspneic; able to speak in full sentences versus single words
- Position: Sitting upright (orthopnea), tripod position (severe obstruction), leaning forward
- Respiratory effort: Use of accessory muscles (sternocleidomastoid, scalenes, intercostals); nasal flaring; pursed-lip breathing
- Breathing pattern: Tachypnea, Cheyne-Stokes respiration, Kussmaul breathing (deep, rapid—metabolic acidosis)
- Color: Cyanosis (central versus peripheral), pallor, plethora
- Body habitus: Cachexia (chronic obstructive pulmonary disease, malignancy), obesity, barrel chest
- Audible sounds: Stridor, wheeze, grunting
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute); bradypnea (less than 12) | Tachypnea: hypoxemia, acidosis, pain, anxiety. Bradypnea: narcotic overdose, neurological injury, impending respiratory failure |
| Oxygen Saturation | Less than 94% on room air; note if on supplemental oxygen | Hypoxemia confirms cardiopulmonary pathology; normal saturation does not exclude serious disease (pulmonary embolism may have normal saturation) |
| Heart Rate | Tachycardia (greater than 100 beats per minute); bradycardia; irregularity | Tachycardia: hypoxemia, anemia, heart failure, pulmonary embolism, fever, anxiety. Irregular: atrial fibrillation |
| Blood Pressure | Hypotension; hypertension; pulsus paradoxus (greater than 10 mmHg drop on inspiration) | Hypotension: cardiogenic shock, massive pulmonary embolism, tension pneumothorax. Pulsus paradoxus: severe asthma, tamponade |
| Temperature | Fever; hypothermia | Fever: pneumonia, sepsis, pulmonary embolism (low-grade). Hypothermia: sepsis, exposure |
Head and Neck Examination
Head
- Conjunctivae: Pallor (anemia), injection (hypercapnia)
- Lips: Central cyanosis, pursed-lip breathing
- Oral cavity: Mucosal cyanosis, angioedema, thrush (immunosuppression)
Neck
- Jugular venous pressure: Elevated in heart failure, cor pulmonale, tamponade, tension pneumothorax
- Tracheal position: Deviation away from tension pneumothorax or large effusion; toward collapse or fibrosis
- Lymphadenopathy: Malignancy, infection, sarcoidosis
- Thyroid: Goiter (tracheal compression), signs of thyroid disease
- Accessory muscle use: Sternocleidomastoid and scalene contraction indicates severe respiratory distress
Respiratory Examination
Inspection
- Chest shape: Barrel chest (hyperinflation), kyphoscoliosis, pectus deformities
- Chest wall movement: Symmetry, paradoxical movement (flail chest, diaphragmatic paralysis)
- Scars: Previous thoracotomy, chest tube sites
- Intercostal recession: Indicates increased work of breathing
Palpation
- Chest expansion: Reduced globally (chronic obstructive pulmonary disease, restrictive disease) or unilaterally (effusion, pneumothorax, collapse)
- Tactile fremitus: Increased over consolidation; decreased over effusion or pneumothorax
- Subcutaneous emphysema: Crepitus suggests pneumothorax or pneumomediastinum
- Tenderness: Rib fractures, costochondritis
Percussion
- Dullness: Consolidation (pneumonia), pleural effusion, mass
- Hyperresonance: Pneumothorax, hyperinflation (chronic obstructive pulmonary disease, severe asthma)
- Stony dullness: Large pleural effusion
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Reduced breath sounds | Diminished air entry bilaterally or unilaterally | Chronic obstructive pulmonary disease (bilateral), effusion, pneumothorax, collapse (unilateral) |
| Bronchial breathing | Loud, hollow sounds with expiratory phase equal to inspiratory | Consolidation (pneumonia), fibrosis above effusion |
| Polyphonic wheeze | Multiple musical pitches, predominantly expiratory | Asthma, chronic obstructive pulmonary disease, bronchitis |
| Monophonic wheeze | Single fixed pitch, may be inspiratory or expiratory | Fixed airway obstruction (tumor, foreign body) |
| Stridor | High-pitched, predominantly inspiratory, heard over trachea | Upper airway obstruction (epiglottitis, anaphylaxis, foreign body, tumor) |
| Fine crackles (rales) | High-pitched, discontinuous, end-inspiratory, “Velcro-like” | Interstitial lung disease, early pulmonary edema, atelectasis |
| Coarse crackles | Low-pitched, early inspiratory, may clear with cough | Bronchiectasis, pneumonia, pulmonary edema |
| Pleural rub | Creaking, grating sound, heard in both phases | Pleuritis, pulmonary embolism, pneumonia |
Cardiovascular Examination
| Finding | How to Assess | Clinical Significance |
|---|---|---|
| Jugular venous pressure | Height above sternal angle at 45 degrees; normally less than 4 cm | Elevated: right heart failure, cor pulmonale, tamponade, constrictive pericarditis, fluid overload |
| Apex beat | Location, character (sustained, displaced, diffuse) | Displaced laterally: left ventricular dilatation. Sustained: left ventricular hypertrophy |
| Heart sounds | First and second heart sounds; additional sounds | Third heart sound (S3): volume overload, heart failure. Fourth heart sound (S4): stiff ventricle, hypertension, ischemia |
| Murmurs | Timing, location, radiation, character | Mitral regurgitation and aortic stenosis common in heart failure; new murmur may indicate acute valvular pathology |
| Peripheral edema | Pitting versus non-pitting; extent (ankles, sacrum) | Bilateral pitting: heart failure, cor pulmonale. Unilateral: consider deep vein thrombosis |
| Peripheral pulses | Rate, rhythm, volume, character | Irregularly irregular: atrial fibrillation. Weak and thready: low cardiac output |
Abdominal and Extremity Examination
Abdominal Findings
- Hepatomegaly: Right heart failure, hepatic congestion
- Hepatojugular reflux: Sustained rise in jugular venous pressure with abdominal compression suggests heart failure
- Ascites: Heart failure, hepatic disease, malignancy
- Obesity: Central obesity limits diaphragmatic excursion
Extremity Findings
- Clubbing: Interstitial lung disease, bronchiectasis, lung cancer, cyanotic heart disease
- Cyanosis: Peripheral (poor perfusion) versus central (hypoxemia)
- Edema: Bilateral lower extremity edema in heart failure; unilateral suggests deep vein thrombosis
- Calf tenderness or swelling: Deep vein thrombosis (consider pulmonary embolism)
- Muscle wasting: Cachexia from chronic disease
Expected Findings by Etiology
| Condition | General Appearance | Respiratory Findings | Cardiovascular and Other Findings |
|---|---|---|---|
| Heart failure | Orthopneic, may appear comfortable at rest | Bilateral basal crackles, possible wheeze (“cardiac asthma”) | Elevated jugular venous pressure, S3 gallop, displaced apex, peripheral edema, hepatomegaly |
| Chronic obstructive pulmonary disease | Barrel chest, pursed-lip breathing, cachexia, tripod position | Hyperresonance, reduced breath sounds, prolonged expiration, wheeze | May have cor pulmonale signs (elevated jugular venous pressure, edema) in advanced disease |
| Asthma exacerbation | Anxious, sitting forward, using accessory muscles | Diffuse polyphonic wheeze; CAUTION: silent chest indicates severe obstruction | Tachycardia, pulsus paradoxus if severe |
| Pneumonia | Febrile, may appear toxic | Focal crackles, bronchial breathing, dullness to percussion, increased fremitus | Tachycardia, may have signs of sepsis |
| Pulmonary embolism | Anxious, may appear well or in extremis | Often normal; may have reduced breath sounds, pleural rub | Tachycardia, elevated jugular venous pressure (if massive), unilateral leg swelling |
| Pneumothorax | Sudden onset, may be in distress (tension) or comfortable (simple) | Unilateral reduced breath sounds, hyperresonance, reduced expansion | Tension: tracheal deviation away, hypotension, elevated jugular venous pressure |
| Interstitial lung disease | May appear comfortable at rest; clubbing | Fine “Velcro” crackles at bases, reduced expansion | Clubbing; signs of underlying connective tissue disease |
| Pleural effusion | May prefer lying on affected side | Stony dullness, reduced breath sounds, reduced expansion on affected side | May have signs of underlying cause (heart failure, malignancy) |
| Anemia | Pallor, may appear well at rest | Usually normal | Tachycardia, flow murmur, conjunctival pallor, koilonychia |
Important Teaching Point
Normal examination does not exclude serious pathology! Several important causes of dyspnea frequently present with a normal or near-normal physical examination:
- Pulmonary embolism: Examination may be entirely normal, especially in smaller emboli
- Early heart failure: May have no crackles or edema, particularly with compensated or diastolic dysfunction
- Asthma between exacerbations: Often completely normal when not symptomatic
- Anemia: May only show pallor and tachycardia
- Anxiety and hyperventilation: Typically normal examination
A normal examination should prompt consideration of these diagnoses and guide appropriate investigations—never dismiss dyspnea based solely on a normal physical examination.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Dyspnea (Onset: Minutes to Hours)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON | Acute asthma exacerbation | Known asthmatic, wheeze, triggers identified, responds to bronchodilators | Silent chest, inability to speak, altered consciousness |
| COMMON | Acute heart failure exacerbation | Known heart failure, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, weight gain | Hypotension, cardiogenic shock, respiratory failure |
| COMMON | Pneumonia | Fever, productive cough, pleuritic pain, focal examination findings | Sepsis, hypoxemia, multilobar involvement |
| COMMON | Chronic obstructive pulmonary disease exacerbation | Known chronic obstructive pulmonary disease, increased sputum, worsening wheeze | Altered mental status (hypercapnia), severe hypoxemia |
| LESS COMMON | Pulmonary embolism | Sudden onset, pleuritic pain, risk factors (immobility, surgery, malignancy, oral contraceptives) | Syncope, hypotension, right heart strain |
| LESS COMMON | Acute coronary syndrome | Chest pressure, diaphoresis, risk factors, may present as “anginal equivalent” | ST elevation, hemodynamic instability |
| LESS COMMON | Anxiety or panic attack | Perioral tingling, palpitations, fear, hyperventilation, prior episodes | Diagnosis of exclusion—rule out organic causes first |
| UNCOMMON BUT SERIOUS | Pneumothorax | Sudden onset, pleuritic pain, unilateral reduced breath sounds, tall thin habitus or trauma | Tension pneumothorax: hypotension, tracheal deviation, cardiovascular collapse |
| UNCOMMON BUT SERIOUS | Anaphylaxis | Exposure to allergen, urticaria, angioedema, stridor, wheeze, hypotension | Airway compromise, cardiovascular collapse |
| UNCOMMON BUT SERIOUS | Cardiac tamponade | Beck’s triad (hypotension, elevated jugular venous pressure, muffled heart sounds), pulsus paradoxus | Cardiovascular collapse, electrical alternans on ECG |
| UNCOMMON BUT SERIOUS | Upper airway obstruction | Stridor, drooling, difficulty swallowing, foreign body history | Complete obstruction, inability to phonate |
Subacute Dyspnea (Onset: Days to Weeks)
| Probability | Condition | Key Features | Expected Course |
|---|---|---|---|
| COMMON | Pneumonia (slow to resolve) | Persistent fever, cough, incomplete response to antibiotics | Should improve over 1 to 2 weeks; consider resistant organism or complication if not |
| COMMON | Pleural effusion | Dullness to percussion, reduced breath sounds, may have pleuritic pain | Depends on cause; may accumulate over days to weeks |
| COMMON | Worsening heart failure | Progressive orthopnea, edema, weight gain, medication non-adherence | Progressive without treatment; responds to diuresis |
| LESS COMMON | Anemia (progressive) | Fatigue, pallor, exertional dyspnea, possible gastrointestinal bleeding | Progressive until cause addressed |
| LESS COMMON | Subacute pulmonary embolism | Recurrent small emboli, progressive dyspnea, may lack classic presentation | Progressive; risk of sudden deterioration |
| UNCOMMON BUT SERIOUS | Lung malignancy | Smoking history, weight loss, hemoptysis, persistent cough | Progressive; urgent investigation required |
| UNCOMMON BUT SERIOUS | Hypersensitivity pneumonitis | Exposure history (birds, mold), fever, dry cough, weight loss | May resolve with exposure removal; can progress to fibrosis |
Chronic Dyspnea (Duration: Greater Than 4 Weeks)
Step-by-Step Approach to Chronic Dyspnea:
- Step 1: Rule out obvious causes — Is the patient a smoker? Taking beta-blockers or angiotensin-converting enzyme inhibitors? Obese? Deconditioned?
- Step 2: Consider the “Big Four” — Asthma, chronic obstructive pulmonary disease, heart failure, and obesity or deconditioning account for approximately 85% of chronic dyspnea in primary care
- Step 3: Evaluate for less common causes if initial workup negative — Interstitial lung disease, pulmonary hypertension, anemia, thyroid disease
- Step 4: Consider multiple overlapping causes — Up to two-thirds of patients have more than one contributing factor
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Chronic obstructive pulmonary disease | 25 to 30% | Smoking history, chronic productive cough, progressive exertional dyspnea, airflow obstruction on spirometry |
| COMMON | Asthma | 25 to 30% | Episodic symptoms, triggers, nocturnal symptoms, wheeze, atopy, reversible obstruction |
| COMMON | Heart failure | 15 to 20% | Orthopnea, paroxysmal nocturnal dyspnea, edema, history of cardiac disease, elevated B-type natriuretic peptide |
| COMMON | Obesity and deconditioning | 10 to 15% | Gradual onset, proportional to activity, elevated body mass index, sedentary lifestyle, no other findings |
| LESS COMMON | Interstitial lung disease | 5 to 10% | Progressive dyspnea, dry cough, “Velcro” crackles, clubbing, restrictive pattern on spirometry |
| LESS COMMON | Anemia | 3 to 5% | Fatigue, pallor, exertional symptoms, low hemoglobin, may have obvious bleeding source |
| LESS COMMON | Pulmonary hypertension | 2 to 3% | Exertional dyspnea, syncope, loud P2, right heart failure signs, often normal chest radiograph |
| UNCOMMON | Chronic thromboembolic pulmonary hypertension | 1 to 2% | History of pulmonary embolism, progressive exertional dyspnea, right heart failure |
| UNCOMMON | Neuromuscular disease | Less than 1% | Orthopnea (early sign), limb weakness, dysphagia, reduced maximal inspiratory pressure |
| UNCOMMON | Thyroid disease | Less than 1% | Hyperthyroidism: palpitations, weight loss, tremor. Hypothyroidism: fatigue, weight gain, pleural effusion |
Anatomical Approach to Dyspnea
Upper Airway
Anaphylaxis and angioedema
Epiglottitis
Foreign body aspiration
Vocal cord dysfunction
Laryngeal tumor
Tracheal stenosis
Lower Airways
Asthma
Chronic obstructive pulmonary disease
Bronchiectasis
Bronchitis
Endobronchial tumor
Foreign body (distal)
Lung Parenchyma and Pleura
Pneumonia
Interstitial lung disease
Pulmonary edema
Pleural effusion
Pneumothorax
Lung malignancy
Cardiovascular and Other
Heart failure
Pulmonary embolism
Pulmonary hypertension
Anemia
Metabolic acidosis
Anxiety and panic disorder
Drug-Induced Dyspnea
| Drug or Drug Class | Mechanism | Characteristics | Time to Resolution After Stopping |
|---|---|---|---|
| Beta-blockers (non-selective) | Bronchospasm in susceptible patients; reduced exercise tolerance | Wheeze, worsening of asthma or chronic obstructive pulmonary disease; exertional limitation | Days to 1 to 2 weeks |
| Amiodarone | Pulmonary toxicity (pneumonitis, fibrosis) | Dry cough, progressive dyspnea, ground-glass opacities on CT; dose and duration related | Weeks to months; may be irreversible |
| Methotrexate | Hypersensitivity pneumonitis; interstitial lung disease | Dry cough, fever, dyspnea; can occur at any time during treatment | Weeks with corticosteroids; may be permanent |
| Nitrofurantoin | Acute hypersensitivity or chronic pulmonary fibrosis | Acute: fever, dyspnea, eosinophilia. Chronic: insidious onset after months of use | Acute: days. Chronic: may be irreversible |
| Bleomycin | Pulmonary fibrosis (dose-related, potentiated by oxygen and radiation) | Dry cough, progressive dyspnea, bibasilar crackles | May be irreversible; progressive even after stopping |
| Nonsteroidal anti-inflammatory drugs and aspirin | Bronchospasm in aspirin-exacerbated respiratory disease | Nasal polyps, asthma, severe bronchospasm after ingestion | Hours (acute reaction) |
| Angiotensin-converting enzyme inhibitors | Bradykinin-mediated cough; rare angioedema | Persistent dry cough perceived as dyspnea; angioedema with stridor | Cough: 1 to 4 weeks. Angioedema: hours |
| Opioids | Central respiratory depression | Reduced respiratory rate, somnolence, hypercapnia | Hours (depends on half-life); naloxone reverses |
| Chemotherapy agents (various) | Pulmonary toxicity, pneumonitis, fibrosis | Variable presentation; often dose-related | Variable; may be irreversible |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Sudden onset with pleuritic chest pain | Pulmonary embolism or pneumothorax | ECG, chest radiograph, D-dimer or CT pulmonary angiogram |
| Orthopnea and paroxysmal nocturnal dyspnea | Heart failure | B-type natriuretic peptide, echocardiogram, chest radiograph |
| Episodic wheeze with triggers | Asthma | Spirometry with bronchodilator response, peak flow diary |
| Smoker with chronic productive cough | Chronic obstructive pulmonary disease | Spirometry showing fixed obstruction |
| Progressive dyspnea with “Velcro” crackles | Interstitial lung disease | High-resolution CT chest, pulmonary function tests |
| Unilateral leg swelling with acute dyspnea | Deep vein thrombosis with pulmonary embolism | Wells score, D-dimer, CT pulmonary angiogram, leg ultrasound |
| Stridor with urticaria after exposure | Anaphylaxis | Intramuscular epinephrine immediately |
| Pallor with fatigue and exertional dyspnea | Anemia | Complete blood count, reticulocyte count, iron studies |
| Dyspnea with perioral tingling and normal examination | Hyperventilation or panic disorder | Rule out organic causes first; consider psychiatric evaluation |
| Exertional syncope with dyspnea | Pulmonary hypertension or severe aortic stenosis | Echocardiogram, consider right heart catheterization |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Unexplained Dyspnea
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Chest radiograph | Screen for parenchymal disease, effusions, cardiomegaly | Infiltrates, masses, effusion, pneumothorax, cardiomegaly, pulmonary edema | Normal in pulmonary embolism, early heart failure, asthma; does not exclude serious pathology |
| Electrocardiogram (ECG) | Evaluate cardiac rhythm, ischemia, strain patterns | Arrhythmia, ST changes, right heart strain (S1Q3T3), left ventricular hypertrophy | May be normal in pulmonary embolism; nonspecific changes common |
| Complete blood count | Detect anemia, infection, polycythemia | Low hemoglobin, elevated white blood cell count, polycythemia (chronic hypoxemia) | Anemia may be sole cause or contributory; leukocytosis suggests infection |
| Basic metabolic panel | Assess renal function, electrolytes, acidosis | Elevated creatinine, metabolic acidosis (low bicarbonate), electrolyte abnormalities | Renal failure causes volume overload; metabolic acidosis increases respiratory drive |
| Pulse oximetry | Assess oxygenation | Oxygen saturation less than 94% | Normal saturation does not exclude pulmonary embolism; may be falsely normal with carbon monoxide |
| Spirometry | Evaluate for obstructive or restrictive pattern | Reduced FEV1/FVC ratio (obstruction), reduced FVC with normal ratio (restriction) | Essential for diagnosing asthma and chronic obstructive pulmonary disease; effort-dependent |
Second-Line Investigations Based on Initial Findings
| Investigation | When to Order | Key Findings |
|---|---|---|
| B-type natriuretic peptide (BNP) or N-terminal pro-BNP | Suspected heart failure; to differentiate cardiac from pulmonary dyspnea | BNP greater than 100 pg/mL or NT-proBNP greater than 300 pg/mL suggests heart failure; very high negative predictive value when low |
| D-dimer | Low to intermediate pretest probability for pulmonary embolism | Negative D-dimer with low pretest probability essentially rules out pulmonary embolism; elevated D-dimer is nonspecific |
| Arterial blood gas | Severe dyspnea, hypoxemia, suspected hypercapnia or acid-base disturbance | Hypoxemia, hypercapnia, respiratory or metabolic acidosis, elevated A-a gradient |
| Troponin | Suspected acute coronary syndrome; risk stratification in pulmonary embolism | Elevated in myocardial infarction; mildly elevated in massive pulmonary embolism, myocarditis |
| Thyroid function tests | Unexplained dyspnea, especially with palpitations, weight changes, or atrial fibrillation | Hyperthyroidism or hypothyroidism as contributing factors |
Targeted Investigations by Suspected Etiology
If Suspecting Heart Failure
First-Line Tests
- BNP or NT-proBNP: BNP greater than 100 pg/mL or NT-proBNP greater than 300 pg/mL supports diagnosis; lower values make heart failure unlikely
- Chest radiograph: Cardiomegaly, pulmonary venous congestion, Kerley B lines, pleural effusions
- ECG: Left ventricular hypertrophy, prior infarction, atrial fibrillation, conduction abnormalities
Second-Line Tests
- Echocardiogram: Assess ejection fraction, wall motion abnormalities, valvular disease, diastolic function, pulmonary pressures
- Stress testing: If ischemia suspected as cause of heart failure
- Cardiac MRI: For specific cardiomyopathy diagnosis, infiltrative disease
If Suspecting Asthma or Chronic Obstructive Pulmonary Disease
First-Line Tests
- Spirometry: FEV1/FVC less than 0.70 indicates obstruction; post-bronchodilator improvement of greater than 12% and 200 mL supports asthma
- Peak expiratory flow: Variability greater than 20% over 2 weeks supports asthma diagnosis
- Chest radiograph: Hyperinflation in chronic obstructive pulmonary disease; usually normal in asthma
Second-Line Tests
- Fractional exhaled nitric oxide (FeNO): Greater than 50 parts per billion suggests eosinophilic inflammation (asthma); helpful when spirometry normal
- Methacholine challenge: Positive if FEV1 falls greater than 20% at low dose; confirms airway hyperreactivity when spirometry normal
- Alpha-1 antitrypsin level: In early-onset chronic obstructive pulmonary disease or family history
- Full pulmonary function tests: Lung volumes and diffusing capacity for comprehensive assessment
If Suspecting Pulmonary Embolism
First-Line Tests
- Wells score or Geneva score: Determines pretest probability; guides further testing
- D-dimer: Negative result with low pretest probability excludes pulmonary embolism; do not use if high pretest probability
Second-Line Tests
- CT pulmonary angiogram: Gold standard imaging; shows filling defects in pulmonary arteries
- Ventilation-perfusion scan: Alternative if CT contraindicated (contrast allergy, renal failure, pregnancy)
- Lower extremity Doppler ultrasound: Positive deep vein thrombosis in appropriate setting may obviate need for CT
- Echocardiogram: Right ventricular strain suggests massive or submassive pulmonary embolism
If Suspecting Interstitial Lung Disease
First-Line Tests
- High-resolution CT chest: Pattern recognition (usual interstitial pneumonia, nonspecific interstitial pneumonia, hypersensitivity pneumonitis patterns)
- Pulmonary function tests: Restrictive pattern (reduced total lung capacity), reduced diffusing capacity (DLCO)
Second-Line Tests
- Autoimmune panel: Antinuclear antibody, rheumatoid factor, anti-cyclic citrullinated peptide, myositis panel for connective tissue disease-associated interstitial lung disease
- Bronchoalveolar lavage: Cell differentials help distinguish patterns
- Surgical lung biopsy: When diagnosis uncertain after non-invasive workup; discuss at multidisciplinary conference
If Suspecting Pulmonary Hypertension
First-Line Tests
- Echocardiogram: Estimated pulmonary artery systolic pressure; right ventricular size and function; tricuspid regurgitation velocity greater than 2.8 m/s suggests pulmonary hypertension
- ECG: Right axis deviation, right ventricular hypertrophy, P pulmonale
Second-Line Tests
- Right heart catheterization: Definitive diagnosis; mean pulmonary artery pressure greater than 20 mmHg confirms pulmonary hypertension
- Ventilation-perfusion scan: To evaluate for chronic thromboembolic pulmonary hypertension
- Six-minute walk test: Functional assessment and prognostication
- CT pulmonary angiogram: Assess for chronic thromboemboli, parenchymal disease
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach for Unexplained Chronic Dyspnea
When initial investigations are inconclusive, empiric treatment trials can help identify treatable causes. Response to therapy supports the diagnosis:
- Trial 1 — Inhaled corticosteroid and bronchodilator: 4 to 8 weeks — tests for occult asthma or eosinophilic airway disease; monitor symptoms and peak flow
- Trial 2 — Proton pump inhibitor: 4 to 8 weeks — tests for gastroesophageal reflux disease-related dyspnea; use twice-daily dosing
- Trial 3 — Diuretic: 1 to 2 weeks — tests for occult heart failure or fluid retention; monitor weight and symptoms
- Trial 4 — Supervised exercise program: 6 to 12 weeks — tests for deconditioning; improvement supports this diagnosis
Important: Document response objectively (symptom scores, exercise tolerance, peak flow) before concluding a trial was successful or unsuccessful.
Common Investigation Pitfalls
Avoid These Diagnostic Errors
- Over-relying on normal chest radiograph: Pulmonary embolism, early heart failure, asthma, and anemia all may have normal chest radiographs
- Checking D-dimer in high pretest probability pulmonary embolism: Proceed directly to CT pulmonary angiogram; D-dimer cannot rule out pulmonary embolism when clinical suspicion is high
- Stopping at one diagnosis: Up to two-thirds of patients have multiple contributing causes; continue evaluation even after finding one cause
- Ignoring normal spirometry: Asthma may have normal spirometry between exacerbations; consider methacholine challenge or fractional exhaled nitric oxide
- Forgetting medication causes: Always review medication list; beta-blockers and amiodarone are commonly overlooked
- Attributing dyspnea to anxiety without workup: Anxiety is a diagnosis of exclusion; organic causes must be ruled out first
Investigation Algorithm Summary
Stepwise Approach:
- All patients: Chest radiograph, ECG, complete blood count, basic metabolic panel, pulse oximetry, spirometry
- If cardiac suspected: Add BNP or NT-proBNP → echocardiogram if elevated or clinical suspicion high
- If pulmonary embolism suspected: Calculate Wells score → D-dimer if low-intermediate probability → CT pulmonary angiogram if positive or high probability
- If obstructive lung disease suspected: Full spirometry with bronchodilator → consider fractional exhaled nitric oxide, methacholine challenge if normal
- If interstitial lung disease suspected: High-resolution CT chest → pulmonary function tests → autoimmune panel → consider bronchoscopy or biopsy
- If still unexplained: Consider empiric treatment trials, cardiopulmonary exercise testing, or referral to specialist
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Respiratory arrest, severe hypoxemia (SpO2 less than 85%), altered consciousness, shock | IMMEDIATE | Airway management, high-flow oxygen, IV access, call for help, prepare for intubation |
| Stridor, anaphylaxis signs, tension pneumothorax features | IMMEDIATE | Epinephrine for anaphylaxis; needle decompression for tension pneumothorax; secure airway |
| Acute pulmonary edema with respiratory failure | EMERGENT | Sit upright, high-flow oxygen, IV furosemide, nitrates if hypertensive, consider non-invasive ventilation |
| Suspected massive pulmonary embolism (hypotension, syncope) | EMERGENT | IV fluids cautiously, anticoagulation, consider thrombolysis, urgent CT or bedside echocardiogram |
| Severe asthma exacerbation (silent chest, inability to speak) | EMERGENT | Continuous nebulized bronchodilators, IV corticosteroids, magnesium sulfate, prepare for intubation |
| Suspected acute coronary syndrome with dyspnea | URGENT | ECG within 10 minutes, aspirin, troponin, oxygen if hypoxic, cardiology consultation |
| Pneumonia with sepsis criteria | URGENT | Blood cultures, IV antibiotics within 1 hour, fluid resuscitation, lactate level |
| New-onset dyspnea with clear lungs and risk factors for pulmonary embolism | URGENT | Calculate Wells score, D-dimer or CT pulmonary angiogram, anticoagulate if high suspicion |
| Stable patient with chronic dyspnea, no red flags | ROUTINE | Systematic outpatient workup with baseline investigations, spirometry, BNP |
| Gradual worsening of known chronic obstructive pulmonary disease or heart failure | ROUTINE TO URGENT | Optimize current therapy, identify exacerbating factors, consider specialist referral |
Step 2: Classify by Duration
Acute (Minutes to Hours)
Proceed to Algorithm A
Focus on life-threatening causes: pulmonary embolism, pneumothorax, acute coronary syndrome, anaphylaxis, severe asthma, acute heart failure
Subacute (Days to Weeks)
Proceed to Algorithm B
Consider: pneumonia, pleural effusion, progressive heart failure, anemia, subacute pulmonary embolism, malignancy
Chronic (Greater Than 4 Weeks)
Proceed to Algorithm C
Systematic evaluation for the “Big Four”: asthma, chronic obstructive pulmonary disease, heart failure, obesity and deconditioning
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Sudden onset, pleuritic pain, risk factors (immobility, surgery, malignancy, oral contraceptives) | Pulmonary embolism | Wells score → D-dimer (if low-intermediate) or CT pulmonary angiogram (if high probability) |
| Sudden onset, unilateral reduced breath sounds, hyperresonance, young tall patient or trauma | Pneumothorax | Chest radiograph; if tension features, immediate needle decompression then chest tube |
| Known asthmatic, wheeze, exposure to trigger, responds to bronchodilator | Acute asthma exacerbation | Nebulized bronchodilators, systemic corticosteroids, assess severity (peak flow, ability to speak) |
| Orthopnea, bilateral crackles, elevated jugular venous pressure, peripheral edema, known cardiac disease | Acute decompensated heart failure | Sit upright, oxygen, IV diuretics, nitrates if hypertensive, BNP, chest radiograph, echocardiogram |
| Fever, productive cough, focal crackles, consolidation on examination | Pneumonia | Chest radiograph, blood cultures if severe, antibiotics based on severity assessment (CURB-65 or PSI) |
| Chest pressure, diaphoresis, risk factors, ECG changes | Acute coronary syndrome | ECG, troponin, aspirin, anticoagulation, cardiology consultation |
| Exposure to allergen, urticaria, angioedema, stridor, hypotension | Anaphylaxis | Intramuscular epinephrine immediately, remove trigger, IV fluids, antihistamines, corticosteroids |
Algorithm B: Subacute Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Persistent fever, cough, incomplete response to antibiotics | Complicated pneumonia or resistant organism | Repeat chest radiograph or CT, consider bronchoscopy, broaden antibiotic coverage |
| Dullness to percussion, reduced breath sounds, history of malignancy or heart failure | Pleural effusion | Chest radiograph and ultrasound, diagnostic thoracentesis, analyze fluid (Light’s criteria) |
| Progressive orthopnea, weight gain, medication non-adherence | Worsening heart failure | Optimize diuretics, review medications and diet, identify precipitants, echocardiogram if not recent |
| Fatigue, pallor, exertional limitation, possible gastrointestinal symptoms | Progressive anemia | Complete blood count, reticulocyte count, iron studies, evaluate for bleeding source |
| Smoking history, weight loss, hemoptysis, persistent cough | Lung malignancy | CT chest with contrast, bronchoscopy, staging investigations if mass identified |
| Exposure history (birds, mold), fever, dry cough, weight loss | Hypersensitivity pneumonitis | High-resolution CT, pulmonary function tests, serum precipitins, remove exposure |
Algorithm C: Chronic Dyspnea
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Episodic wheeze, nocturnal symptoms, atopy, triggers identified | Asthma | Spirometry with bronchodilator; if normal, peak flow diary, fractional exhaled nitric oxide, or methacholine challenge |
| Smoking history greater than 10 pack-years, chronic productive cough, progressive exertional limitation | Chronic obstructive pulmonary disease | Spirometry showing fixed obstruction (post-bronchodilator FEV1/FVC less than 0.70), smoking cessation, inhaler therapy |
| Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, history of hypertension or coronary disease | Heart failure | BNP or NT-proBNP, echocardiogram, optimize medical therapy (beta-blocker, ACE inhibitor, diuretic) |
| Elevated body mass index, sedentary lifestyle, dyspnea proportional to activity, no other findings | Obesity and deconditioning | Exclude other causes, weight loss program, supervised exercise rehabilitation |
| Progressive dyspnea, dry cough, “Velcro” crackles, clubbing | Interstitial lung disease | High-resolution CT, pulmonary function tests with diffusing capacity, autoimmune panel, pulmonology referral |
| Exertional dyspnea with syncope, loud P2, right heart failure signs | Pulmonary hypertension | Echocardiogram, right heart catheterization, evaluate for chronic thromboembolic disease, pulmonology or cardiology referral |
| Normal initial workup, episodic symptoms, associated anxiety | Anxiety or panic disorder (diagnosis of exclusion) | Ensure thorough organic workup complete, consider cardiopulmonary exercise testing, psychiatric evaluation |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient is hypoxic (SpO2 less than 90%) | Apply supplemental oxygen to target SpO2 92 to 96% (88 to 92% if known chronic obstructive pulmonary disease with hypercapnia risk) | Arterial blood gas, chest radiograph, identify and treat underlying cause |
| Patient is on a beta-blocker and has new wheeze | Consider beta-blocker as cause, especially if non-selective; provide bronchodilator | Switch to cardioselective beta-blocker or alternative; reassess in 1 to 2 weeks |
| D-dimer is positive but clinical suspicion is low | D-dimer is nonspecific; positive result requires imaging | Proceed to CT pulmonary angiogram; do not dismiss based on low clinical suspicion alone |
| Spirometry is normal but asthma is suspected | Asthma may have normal spirometry between exacerbations | Peak flow diary for 2 weeks, fractional exhaled nitric oxide, or methacholine challenge |
| BNP is borderline (100 to 400 pg/mL) | Gray zone; clinical correlation essential | Echocardiogram to assess cardiac structure and function; consider other causes |
| Chest radiograph is normal but patient is dyspneic | Normal chest radiograph does not exclude pulmonary embolism, early heart failure, asthma, or anemia | Continue workup based on clinical suspicion; consider CT, spirometry, BNP, complete blood count |
| Patient has both heart failure and chronic obstructive pulmonary disease | Common overlap; treat both conditions | Optimize both cardiac (diuretics, beta-blocker) and pulmonary (bronchodilators, inhaled corticosteroids) therapy; pulmonary rehabilitation |
| Dyspnea persists despite optimal treatment | Reassess diagnosis; consider additional contributing factors | Cardiopulmonary exercise testing, specialist referral, consider palliative approaches for refractory dyspnea |
Troubleshooting Refractory Dyspnea
Ask These Questions When Dyspnea Does Not Respond to Treatment
- Is the diagnosis correct? Reassess clinical features; consider alternative diagnoses
- Are there multiple contributing causes? Up to two-thirds of patients have more than one cause; ensure all are addressed
- Is the patient adherent to treatment? Check inhaler technique, medication compliance, dietary adherence
- Is the treatment adequate? Ensure optimal doses; consider step-up therapy
- Are there ongoing exacerbating factors? Continued smoking, allergen exposure, medication side effects, untreated sleep apnea
- Is there a psychological component? Anxiety and depression worsen dyspnea perception; address mental health
- Would cardiopulmonary exercise testing help? Can differentiate cardiac, pulmonary, deconditioning, and unexplained causes
- Is specialist referral needed? Pulmonology, cardiology, or multidisciplinary dyspnea clinic
When to Refer to a Specialist
| Refer To | When |
|---|---|
| Pulmonology | Suspected interstitial lung disease, unexplained abnormal pulmonary function tests, severe or uncontrolled asthma, consideration of bronchoscopy, pulmonary hypertension evaluation |
| Cardiology | New heart failure diagnosis for optimization, suspected pulmonary hypertension, valvular heart disease, consideration of advanced therapies (implantable cardioverter-defibrillator, cardiac resynchronization therapy) |
| Hematology | Unexplained anemia, suspected hematologic malignancy |
| Thoracic Surgery | Lung mass requiring biopsy, recurrent pneumothorax, consideration of lung volume reduction surgery |
| Palliative Care | Refractory dyspnea in advanced disease, symptom management, goals of care discussions |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
The “Big Four” dominate chronic dyspnea: Asthma, chronic obstructive pulmonary disease, heart failure, and obesity or deconditioning account for approximately 85% of cases in primary care. Start your evaluation here.
Multiple causes are the rule, not the exception: Up to two-thirds of patients with chronic dyspnea have more than one contributing cause. Do not stop your evaluation after finding one diagnosis.
Orthopnea and paroxysmal nocturnal dyspnea are highly specific for heart failure: When patients report waking at night gasping for air or needing multiple pillows, heart failure should be high on your differential regardless of other findings.
BNP is most useful when low: A low B-type natriuretic peptide (less than 100 pg/mL) has excellent negative predictive value for heart failure. Use it to rule out, not rule in.
A normal chest radiograph does not exclude serious disease: Pulmonary embolism, early heart failure, asthma, anemia, and early interstitial lung disease may all have normal chest radiographs. Continue your workup.
Pulmonary embolism is the great masquerader: Consider pulmonary embolism in any patient with unexplained dyspnea, especially with sudden onset, pleuritic pain, or risk factors. The classic triad of dyspnea, chest pain, and hemoptysis is present in fewer than 20% of cases.
Ask about bendopnea: Dyspnea when bending forward (such as tying shoes) is a specific symptom of advanced heart failure with elevated filling pressures. It is often missed because patients are not asked.
The qualitative description matters: “Chest tightness” suggests bronchoconstriction; “air hunger” suggests increased drive (hypoxemia, acidosis); “work to breathe” suggests mechanical load. Listen to how patients describe their breathlessness.
Critical Pitfalls to Avoid
Attributing dyspnea to anxiety without ruling out organic causes: Anxiety is a diagnosis of exclusion. Always complete a thorough workup before concluding that dyspnea is purely psychological. Anxiety and organic disease frequently coexist.
Using D-dimer to rule out pulmonary embolism in high-probability patients: D-dimer is only useful in low to intermediate pretest probability. In high clinical suspicion, proceed directly to CT pulmonary angiogram regardless of D-dimer result.
Forgetting to review the medication list: Beta-blockers, amiodarone, methotrexate, and nitrofurantoin are commonly overlooked causes of dyspnea. Always ask about all medications including over-the-counter drugs.
Assuming normal spirometry excludes asthma: Spirometry may be normal between exacerbations. If asthma is suspected clinically, pursue peak flow variability, fractional exhaled nitric oxide, or bronchoprovocation testing.
Missing “silent” asthma exacerbations: Absence of wheeze in severe asthma indicates minimal air movement and impending respiratory failure—not improvement. A “silent chest” is an ominous sign requiring immediate escalation.
Relying on oxygen saturation alone: Patients can be severely dyspneic with normal oxygen saturation. Saturation also does not reflect carbon dioxide levels or work of breathing. Use arterial blood gas when needed.
Stopping at one diagnosis: Finding asthma does not exclude coexisting heart failure. Finding chronic obstructive pulmonary disease does not exclude anemia. Always consider whether additional factors are contributing.
Dismissing dyspnea in obese patients as “just obesity”: While obesity does cause dyspnea, it also increases the risk of heart failure, sleep apnea, pulmonary hypertension, and venous thromboembolism. Complete a thorough evaluation before attributing symptoms solely to weight.
Key Takeaways
- Dyspnea is a subjective symptom—severity does not always correlate with objective findings like oxygen saturation or chest radiograph abnormalities
- Classify by duration first: acute dyspnea requires urgent evaluation for life-threatening causes; chronic dyspnea allows systematic outpatient workup
- The “Big Four” (asthma, chronic obstructive pulmonary disease, heart failure, deconditioning and obesity) cause approximately 85% of chronic dyspnea—but most patients have multiple contributing factors
- Orthopnea and paroxysmal nocturnal dyspnea are highly specific for heart failure; their presence should prompt cardiac evaluation
- Pulmonary embolism should be considered in any patient with unexplained acute dyspnea, particularly with risk factors; the classic presentation is uncommon
- A normal physical examination does not exclude serious pathology—pulmonary embolism, early heart failure, and asthma between exacerbations may all have normal examinations
- BNP is most valuable as a “rule-out” test; a low value makes heart failure very unlikely
- Always review the medication list—drug-induced dyspnea (beta-blockers, amiodarone, methotrexate) is commonly missed
- When initial workup is negative, consider empiric treatment trials (bronchodilators, proton pump inhibitors, diuretics) as diagnostic tools
- Anxiety and panic disorder cause dyspnea but remain diagnoses of exclusion—complete organic workup before attributing symptoms to psychological causes
Quick Reference Algorithm
Systematic Approach to Dyspnea:
- Assess urgency: Is this life-threatening? Look for red flags (respiratory distress, hypoxemia, hemodynamic instability, stridor). Stabilize and treat emergent conditions first.
- Classify by duration: Acute (minutes to hours), subacute (days to weeks), or chronic (greater than 4 weeks). This guides differential diagnosis and urgency of workup.
- Take a focused history: Use the BREATHE mnemonic. Ask about orthopnea, paroxysmal nocturnal dyspnea, triggers, timing, and associated symptoms. Review medications and smoking history.
- Perform systematic examination: Vital signs, general inspection (distress, accessory muscle use), respiratory examination (breath sounds, percussion), cardiovascular examination (jugular venous pressure, heart sounds, edema).
- Order baseline investigations: Chest radiograph, ECG, complete blood count, basic metabolic panel, oxygen saturation, and spirometry for all patients with unexplained dyspnea.
- Pursue targeted testing based on clinical suspicion: BNP and echocardiogram for heart failure; Wells score and D-dimer or CT pulmonary angiogram for pulmonary embolism; bronchodilator response or methacholine challenge for asthma.
- Consider multiple diagnoses: If one cause is found, ask whether it fully explains the symptoms. Continue evaluation if response to treatment is incomplete.
- Treat and reassess: Optimize therapy for identified conditions. If dyspnea persists, reconsider diagnosis, address adherence, and consider specialist referral or cardiopulmonary exercise testing.